Nefize Turan1, Robert A Heider2, Anil K Roy1, Brandon A Miller1, Mark E Mullins3, Daniel L Barrow1, Jonathan Grossberg1, Gustavo Pradilla4. 1. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA. 2. Department of Radiology, Duke University School of Medicine, Durham, North Carolina, USA. 3. Department of Radiology & Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA. 4. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: gpradil@emory.edu.
Abstract
BACKGROUND: Intracranial aneurysms (IAs) are pathologic dilatations of cerebral arteries. This systematic review summarizes and compares imaging techniques for assessing unruptured IAs (UIAs). This review also addresses their uses in different scopes of practice. Pathophysiologic mechanisms are reviewed to better understand the clinical usefulness of each imaging modality. METHODS: A literature review was performed using PubMed with these search terms: "intracranial aneurysm," "cerebral aneurysm," "magnetic resonance angiography (MRA)," computed tomography angiography (CTA)," "catheter angiography," "digital subtraction angiography," "molecular imaging," "ferumoxytol," and "myeloperoxidase". Only studies in English were cited. RESULTS: Since the development and improvement of noninvasive diagnostic imaging (computed tomography angiography and magnetic resonance angiography), many prospective studies and meta-analyses have compared these tests with gold standard digital subtraction angiography (DSA). Although computed tomography angiography and magnetic resonance angiography have lower detection rates for UIAs, they are vital in the treatment and follow-up of UIAs. The reduction in ionizing radiation and lack of endovascular instrumentation with these modalities provide benefits compared with DSA. Novel molecular imaging techniques to detect inflammation within the aneurysmal wall with the goal of stratifying risk based on level of inflammation are under investigation. CONCLUSIONS: DSA remains the gold standard for preoperative planning and follow-up for patients with IA. Newer imaging modalities such as ferumoxytol-enhanced magnetic resonance imaging are emerging techniques that provide critical in vivo information about the inflammatory milieu within aneurysm walls. With further study, these techniques may provide aneurysm rupture risk and prediction models for individualized patient care.
BACKGROUND:Intracranial aneurysms (IAs) are pathologic dilatations of cerebral arteries. This systematic review summarizes and compares imaging techniques for assessing unruptured IAs (UIAs). This review also addresses their uses in different scopes of practice. Pathophysiologic mechanisms are reviewed to better understand the clinical usefulness of each imaging modality. METHODS: A literature review was performed using PubMed with these search terms: "intracranial aneurysm," "cerebral aneurysm," "magnetic resonance angiography (MRA)," computed tomography angiography (CTA)," "catheter angiography," "digital subtraction angiography," "molecular imaging," "ferumoxytol," and "myeloperoxidase". Only studies in English were cited. RESULTS: Since the development and improvement of noninvasive diagnostic imaging (computed tomography angiography and magnetic resonance angiography), many prospective studies and meta-analyses have compared these tests with gold standard digital subtraction angiography (DSA). Although computed tomography angiography and magnetic resonance angiography have lower detection rates for UIAs, they are vital in the treatment and follow-up of UIAs. The reduction in ionizing radiation and lack of endovascular instrumentation with these modalities provide benefits compared with DSA. Novel molecular imaging techniques to detect inflammation within the aneurysmal wall with the goal of stratifying risk based on level of inflammation are under investigation. CONCLUSIONS: DSA remains the gold standard for preoperative planning and follow-up for patients with IA. Newer imaging modalities such as ferumoxytol-enhanced magnetic resonance imaging are emerging techniques that provide critical in vivo information about the inflammatory milieu within aneurysm walls. With further study, these techniques may provide aneurysm rupture risk and prediction models for individualized patient care.
Authors: J M Sequeiros; J A Roa; R P Sabotin; S Dandapat; S Ortega-Gutierrez; E C Leira; C P Derdeyn; G Bathla; D M Hasan; E A Samaniego Journal: AJNR Am J Neuroradiol Date: 2020-09-17 Impact factor: 3.825
Authors: Redi Rahmani; Jacob F Baranoski; Felipe C Albuquerque; Michael T Lawton; Tomoki Hashimoto Journal: Exp Neurol Date: 2022-03-25 Impact factor: 5.620
Authors: Felix Eisenhut; Manuel Alexander Schmidt; Alexander Kalik; Tobias Struffert; Julian Feulner; Sven-Martin Schlaffer; Michael Manhart; Arnd Doerfler; Stefan Lang Journal: Diagnostics (Basel) Date: 2022-05-04
Authors: Allison Park; Chris Chute; Pranav Rajpurkar; Joe Lou; Robyn L Ball; Katie Shpanskaya; Rashad Jabarkheel; Lily H Kim; Emily McKenna; Joe Tseng; Jason Ni; Fidaa Wishah; Fred Wittber; David S Hong; Thomas J Wilson; Safwan Halabi; Sanjay Basu; Bhavik N Patel; Matthew P Lungren; Andrew Y Ng; Kristen W Yeom Journal: JAMA Netw Open Date: 2019-06-05